Arnold R Oliphant

Title: Innovations of Arnold R Oliphant

Introduction

Arnold R Oliphant is a notable inventor based in Johnston, IA (US). He has made significant contributions to the field of biotechnology, particularly in the study of Mycoplasma arthritidis. With a total of two patents to his name, his work has implications for understanding and potentially treating various diseases.

Latest Patents

Oliphant's latest patents focus on a method of purifying Mycoplasma arthritidis T-cell mitogen (MAM) to achieve electrophoretic and sequence homogeneity. This method has allowed for the determination of the sequence of the N-terminal 54 amino acids of MAM. A synthetic peptide consisting of amino acids 15-32 was found to inhibit MAM-induced cell proliferation in vitro. The MAM gene was sequenced and identified on a 1107 bp DNA fragment, revealing a primary translation product that includes a 39 amino acid signal sequence and a 213 amino acid mature MAM with a molecular weight of 25,294. His research also uncovered sequence homologies to HIV and other retrovirus proteins, which could lead to strategies for blocking or immunizing against certain diseases, including autoimmune diseases.

Career Highlights

Oliphant is affiliated with the University of Utah Research Foundation, where he continues to advance his research in the field of immunology and biotechnology. His work has been instrumental in understanding the mechanisms of T-cell activation and the role of MAM in immune responses.

Collaborations

He has collaborated with notable colleagues such as Barry C Cole and Curtis L Atkin, contributing to a rich environment of innovation and research.

Conclusion

Arnold R Oliphant's contributions to the field of biotechnology through his patents and research have the potential to impact the understanding and treatment of various diseases. His work exemplifies the importance of innovation in advancing scientific knowledge and improving health outcomes.